Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group ; volume:8 ; number:3 ; day:9 ; month:3 ; year:2018 ; pages:1-8 ; date:3.2018
Blood cancer journal ; 8, Heft 3 (9.3.2018), 1-8, 3.2018
- Urheber
-
Katodritou, Eirini
- Beteiligte Personen und Organisationen
-
Terpos, Evangelos
Delimpasi, Sossana
Kotsopoulou, Maria
Michalis, Eurydiki
Vadikolia, Chrysanthi
Kyrtsonis, Marie-Christine
Symeonidis, Argiris
Giannakoulas, Nikolaos
Vadikolia, Chrissa
Michael, Michalis
Kalpadakis, Christina
Gougopoulou, Theodora
Prokopiou, Chrystalla
Kaiafa, Georgia
Christoulas, Dimitrios
Gavriatopoulou, Maria
Giannopoulou, Evlampia
Labropoulou, Vasiliki
Verrou, Evgenia
Kastritis, Efstathios
Konstantinidou, Pavlina
Anagnostopoulos, Achilles
Dimopoulos, Meletios A.
SpringerLink (Online service)
- DOI
-
10.1038/s41408-018-0059-6
- URN
-
urn:nbn:de:1111-201805146122
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:54 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Katodritou, Eirini
- Terpos, Evangelos
- Delimpasi, Sossana
- Kotsopoulou, Maria
- Michalis, Eurydiki
- Vadikolia, Chrysanthi
- Kyrtsonis, Marie-Christine
- Symeonidis, Argiris
- Giannakoulas, Nikolaos
- Vadikolia, Chrissa
- Michael, Michalis
- Kalpadakis, Christina
- Gougopoulou, Theodora
- Prokopiou, Chrystalla
- Kaiafa, Georgia
- Christoulas, Dimitrios
- Gavriatopoulou, Maria
- Giannopoulou, Evlampia
- Labropoulou, Vasiliki
- Verrou, Evgenia
- Kastritis, Efstathios
- Konstantinidou, Pavlina
- Anagnostopoulos, Achilles
- Dimopoulos, Meletios A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population
Emerging agents and regimens for multiple myeloma
Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world data
Greek and Sanskrit: a comparative study
New agents in the Treatment of Myeloma Bone Disease
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland
Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
The Incidence and Timing of Blood Cultures in Multiple Myeloma — Results from a Retrospective, Single Center, Real-World Study
Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population
Emerging agents and regimens for multiple myeloma
Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world data
Greek and Sanskrit: a comparative study
New agents in the Treatment of Myeloma Bone Disease
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland
Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
The Incidence and Timing of Blood Cultures in Multiple Myeloma — Results from a Retrospective, Single Center, Real-World Study
Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population
Emerging agents and regimens for multiple myeloma
Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world data
Greek and Sanskrit: a comparative study
New agents in the Treatment of Myeloma Bone Disease
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland
Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
The Incidence and Timing of Blood Cultures in Multiple Myeloma — Results from a Retrospective, Single Center, Real-World Study